Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

E-MTAB-9806

ABSTRACT: RNA seq of mouse bone marrow derived macrophages treated with Debaryomyces hansenii against untreated controls

PROVIDER: E-MTAB-9806 | ExpressionAtlas | 2020-12-09

REPOSITORIES: ExpressionAtlas

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	E-MTAB-9806-analysis-methods.tsv	Tabular
	E-MTAB-9806-analytics.tsv	Tabular
	E-MTAB-9806-apply_fixes_zooma_mappings.done	Other
	E-MTAB-9806-atlasExperimentSummary.Rdata	Rdata
	E-MTAB-9806-configuration.xml	Xml

Items per page:

1 - 5 of 60

Similar Datasets

RNA seq of mouse bone marrow derived macrophages treated with Debaryomyces hansenii against untreated controls

Project description:RNA seq of mouse bone marrow derived macrophages treated with Debaryomyces hansenii against untreated controls

| PRJEB41525 | ENA

Conditioned medium from bone marrow derived macrophages

Project description:Conditioned medium (CM) from bone marrow derived macrophages untreated or treated with LPS was collected and filtered through a 0.22-μm filter. The filtered CM was sequentially fractionated with 50-kDa and 100-kDa Amicon filters. The 50–100 kDa fraction of CM was analyzed by mass spectrometry.

2022-11-01 | PXD034550 | JPOST Repository

Project description:mouse bone marrow derived macrophages

| PRJNA739555 | ENA

Timecourse of interferon-beta stimulation of mouse bone marrow derived macrophages

Project description:Transcriptomic analysis of the temporal changes induced in mouse bone marrow derived macrophages (BMDMs) by the cytokine Interferon-beta over a timecourse of 0 to 24 hours of treatment. We set out to study the transcriptional events in mouse macrophages over time following stimulation with Interferon-beta. Mouse bone marrow derived macrophages were stimulated for 1, 2, 4, 8 and 24 hours with 10U/mL mouse interferon-beta or left untreated.

2010-02-19 | GSE20403 | GEO

Mus musculus

Project description:Mouse bone marrow cyclophosphamide treated vs untreated

| PRJNA141829 | ENA

Microarray analysis of macrophages derived from mouse bone marrow cells with or without metformin treatment

Project description:In this study, we investigated the effects of metformin on the differentiation of bone marrow-derived macrophages (BMDMs) and their potential role in cancer immunity. BMDMs were generated from bone marrow cells extracted from C57BL/6N mice and differentiated in the presence or absence of metformin. Our transcriptomic analysis, performed using the Clariom S Mouse microarrays, revealed changes in gene expression profiles between metformin-treated and untreated macrophages.

2025-06-13 | E-MTAB-14199 | biostudies-arrayexpress

Proteomic analysis of bone marrow-derived macrophages of mice treated with recombinant Ssa1, a protein enriched in the hypoxic secretome of Candida albicans.

Project description:Bone marrow-derived macrophages from mice were treated with recombinant Ssa1, a protein enriched in the hypoxic secretome of Candida albicans.

2024-01-29 | PXD046766 | JPOST Repository

Itaconate modulates immune responses via inhibition of peroxiredoxins

Project description:Itaconate is a natural mild electrophile, able to modify free thiols in proteins upon activation. We submit two datasets investigating peptides modified by itaconate. Experiment001 contains data obtained from endogenous itaconate producing WT or itaconate incompetent Irg1-/- Bone marrow-derived macrophages stimulated with LPS for 24h. The second dataset from Experiment002 contains data obtained from WT Bone marrow-derived macrophages treated with media or 5 mM itaconic acid for 16h.

2023-11-28 | MSV000093522 | MassIVE

RNA-seq of CYR61-treated murine bone marrow-derived macrophages

Project description:RNA-seq of CYR61-treated murine bone marrow-derived macrophages

| PRJNA917718 | ENA

Mus musculus

Project description:Expression profiles of primary bone marrow derived mouse macrophages – untreated and treated with LPS or LPS+PGE

| PRJNA178264 | ENA